The 13th Aging Research and Drug Discovery Meeting

Biointron will attend the 13th Aging Research and Drug Discovery Meeting (ARDD 2026), held October 1 – 3, 2026, at the David Rubenstein Treehouse at Harvard University. The meeting will also be accessible online. 

ARDD brings together scientists, clinicians, biotechnology and pharmaceutical leaders, investors, and technology developers working to understand the biology of aging and translate emerging discoveries into interventions for age-associated diseases. Discussions will span the molecular, cellular, and organismal mechanisms of aging, as well as the scientific and practical challenges involved in developing therapies that support healthier aging. 

Alongside the main scientific program, ARDD 2026 will feature dedicated forums on longevity medicine, AI in drug discovery, animal longevity, and virtual models of the aging cell. These sessions will provide multidisciplinary perspectives on therapeutic discovery, translational research, computational modeling, and the experimental evidence needed to advance new hypotheses toward drug development. 

Biointron looks forward to meeting researchers and innovators exploring new therapeutic approaches in aging and longevity. Connect with our team at booth #10 to discuss how antibody discovery, high-throughput expression, functional characterization, and rapid wet-lab data generation can support efficient and evidence-driven biologics development. 

For more details about the event, please visit the ARDD 2026 website [https://agingpharma.org/] 

Time: October 1 - 3, 2026 

Location: David Rubenstein Treehouse at Harvard University | Boston, MA 

Booth: #10